These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15721433)

  • 21. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

  • 22. EUROGIN 2007 roadmap on cervical cancer prevention.
    Monsonego J
    Vaccine; 2008 Mar; 26 Suppl 1():A1-3. PubMed ID: 18642466
    [No Abstract]   [Full Text] [Related]  

  • 23. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 24. Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women.
    Charakorn C; Rattanasiri S; Lertkhachonsuk AA; Thanapprapasr D; Chittithaworn S; Wilailak S
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):160-7. PubMed ID: 21585696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-HPV vaccination against cervical cancer].
    Simon P; Monnier S; Buxant F; Noël JC
    Rev Med Brux; 2005; 26(5):433-8. PubMed ID: 16318096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 27. Human papillomavirus vaccines and prevention of cervical cancer.
    Jansen KU; Shaw AR
    Annu Rev Med; 2004; 55():319-31. PubMed ID: 14746524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV-vaccine and screening programs: the new era of global prevention.
    Mariani L
    J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
    [No Abstract]   [Full Text] [Related]  

  • 29. [Human papillomavirus nonavalent vaccine. Update 2017].
    Bosch FX; Moreno D; Redondo E; Torné A
    Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
    Kim JJ
    PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cervical cancer uteri: from the etiology to prophylactic vaccine].
    Vonka V; Hamsíková E
    Cas Lek Cesk; 2006; 145(7):511-21. PubMed ID: 16921777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers.
    Nicol AF; Monsonego J
    Gynecol Oncol; 2011 Nov; 123(2):179-81. PubMed ID: 22008409
    [No Abstract]   [Full Text] [Related]  

  • 33. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 34. Etiology and prevention of cervical adenocarcinomas.
    Hildesheim A; Berrington de González A
    J Natl Cancer Inst; 2006 Mar; 98(5):292-3. PubMed ID: 16507820
    [No Abstract]   [Full Text] [Related]  

  • 35. Delivering on the promise: HPV vaccines and cervical cancer.
    Schiller JT; Davies P
    Nat Rev Microbiol; 2004 Apr; 2(4):343-7. PubMed ID: 15031733
    [No Abstract]   [Full Text] [Related]  

  • 36. EUROGIN 2007 patient education conference: sharing experiences and action in cervical cancer prevention--an overview. Part 2.
    Pagliusi S; Lawson H; Singer A; Monsonego J
    Vaccine; 2008 Mar; 26 Suppl 1():A33-6. PubMed ID: 18642460
    [No Abstract]   [Full Text] [Related]  

  • 37. Additional Protection from 9-Valent HPV Vaccine if Administered Before HPV Exposure.
    Joura E; Clark L; Luxembourg A
    Am Fam Physician; 2016 Feb; 93(4):254-6. PubMed ID: 26926809
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.
    Dillner J; Arbyn M; Dillner L
    Clin Exp Immunol; 2007 May; 148(2):199-207. PubMed ID: 17437418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.